Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CordenPharma announced a >€1 billion strategic investment in peptide development and manufacturing.
read more
Coronado Research has appointed Stephen Ralston as EVP Market Access and Health Economics Outcomes Research (HEOR). With over 25 years of experience providing high-quality strategic Market Access and HEOR solutions, at companies including Genesis ...
read more
Aenova is expanding its Bad Aibling site. With a total investment of around 20 million euros in new production and packaging lines, the site offers a modern, high-volume infrastructure for the production of effervescent products and blister packaging...
read more
Wellgistics Health, Inc. announced that its wholly owned subsidiary, Wellgistics LLC, is collaborating with Protega Pharmaceuticals Inc. Protega is the specialty pharmaceutical company that launched ROXYBOND™ (oxycodone hydrochloride), the first and ...
read more
Axplora is strengthening its position in the commercial manufacturing of ADCs with the launch of a cutting-edge payload manufacturing workshop at its Le Mans site (France).
read more
Veranova announced the move of its corporate headquarters to its Devens, Massachusetts facility, one of the company’s principal sites for manufacturing and development.
read more
Sygnature Discovery has announced the appointment of Kieron Hall as its new Chief Commercial Officer (CCO) and Board member.
read more
Thursday, February 27, 2025
WuXi Biologics announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities (MFG2 and MFG5), in Wuxi city.
read more
Thursday, February 27, 2025
Abzena announced that Taylor Boyd has joined the company as its Chief Business Officer (“CBO”). In this newly created role, Boyd will be responsible for corporate development, portfolio strategy, and partnering strategy activities that drive Abzena’...
read more
Thursday, February 27, 2025
LSPedia has secured its second major U.S. government contract, the MMCAP Infuse DSCSA Compliance contract. This follows its national DSCSA contract with the U.S. Department of Veterans Affairs, further solidifying LSPedia's leadership position in the...
read more
Thursday, February 27, 2025
BullFrog AI Holdings, Inc. announced its entry into a collaboration agreement with Eleison Pharmaceuticals Inc. Under the terms of the agreement, BullFrog AI will provide access to its BullFrog Data Networks™ AI solution to enhance clinical trial ...
read more
Tuesday, February 25, 2025
Rentschler Biopharma SE announced the promotion of Patrick Meyer, Ph.D., to Global Head of Business Development (BD), effective immediately.
read more
Friday, February 21, 2025
Tiziana announced a product development services agreement with Renaissance Lakewood LLC. This collaboration aims to optimize the current formulation and develop a comprehensive plan for the scale-up of foralumab in a nasal device. Intranasal ...
read more
Wednesday, February 19, 2025
Celonic Group announced the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech for the production of catumaxomab for commercial supply.
read more
Wednesday, February 19, 2025
Celerion announced a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health. This state-of-the-art clinical research center, led by Queen’s University Belfast, in partnership with the Belfast Health and Social Care ...
read more